Abstract
Acute thyroid disorders are infrequently observed in clinical practice with a poorly defined incidence. They represent a long-standing dysregulation of thyroid gland, usually precipitated by an acute illness. They are either caused by overt dysfunction resulting in myxoedema coma or hyperfunctioning of the gland giving rise to thyrotoxicosis. Despite utmost care, mortality remains high, 30–50 % in myxoedema coma and 30–40 % in thyroid storm thereby necessitating immediate and aggressive intervention in emergency department.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gavin LA. Thyroid crises. Med Clin N Am. 1991;75:179–93.
Tietgens ST, Leinung MC. Thyroid storm. Med Clin N Am. 1995;79:169–84.
Wartofsky L. Thyrotoxic storm. In: Braverman L, Utiger R, editors. Werner & Ingbar’s the thyroid. 9th ed. Philadelphia: Williams & Wilkins; 2005. p. 651–7.
Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116:1725–35.
Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin N Am. 1993;22(2):263–77.
Akin F, Yaylali GF, Bastemir M. The use of lithium carbonate in the preparation for definitive therapy in hyperthyroid patients. Med Princ Pract. 2008;17(2):167.
Wartofsky L. Thyrotoxic storm. In: Braverman LE, Utiger RD, editors. Werner’s & Ingbar’s the thyroid, 9th ed. Philadelphia: Lippincott Williams and Wilkins; 2005.
Rodríguez I, Fluiters E, Pérez-Méndez LF, Luna R, Páramo C, García-Mayor RV. Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single institution. J Endocrinol. 2004;180(2):347–50.
Dutta P, Bhansali A, Masoodi S, Bhadada S, Sharma N, Rajput R. Predictors of outcome in myxoedema coma: a study from a tertiary care centre. Crit Care. 2008;12(1):R1.
Braverman LE, Utiger RD, editors. Werner and Ingbar’s the thyroid. 8th ed. Philadelphia: Lippincott, Williams and Wilkins; 2000. p. 1081.
Ladenson PW, Goldenheim PD, Ridgway EC. Prediction and reversal of blunted ventilatory responsiveness in patients with hypothyroidism. Am J Med. 1988;84(5):877–83.
Wilson WR, Bedell GN. The pulmonary abnormalities in myxedema. J Clin Invest. 1960;39:42–55.
Massumi RA, Winnacker JL. Severe depression of the respiratory center in myxedema. Am J Med. 1964;36(6):876–82.
Reinhardt W, Mann K. Incidence, clinical picture, and treatment of hypothyroid coma: results of a survey. Med Klin. 1997;92:521–4.
Purnell JQ, Brandon DD, Isabelle LM, Loriaux DL, Samuels MH. Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J Clin Endocrinol Metab. 2004;89:281–7.
Bansal V, Asmar NE, Selman WR, Arafah BM. Pitfalls in the diagnosis and management of Cushing’s syndrome. Neurosurg Focus. 2015;38(2), E4.
Ragnarsson O, Johannsson G. Cushing’s syndrome: a structured short- and long-term management plan for patients in remission. Eur J Endocrinol. 2013;169:R139–52.
Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet. 2006;367:1605–17.
Van der Pas R, Leebeek FW, Hofland LJ, de Herder WW, Feelders RA. Hypercoagulability in Cushing’s syndrome: prevalence, pathogenesis and treatment. Clin Endocrinol (Oxf) 2013;78:481–88. Fernández-Rodríguez E, et al. Severe hypertension and hypokalemia as first clinical manifestations in ectopic Cushing’s syndrome. Endocrinol Metabol. 2008;52(6):1066–70.
Soh LM, Gunganah K, Akker SA, Jones P, Khachi H, Dodzo K, Drake WM. Etomidate in the emergency management of hypercortisolemia. Eur J Endocrinol. 2012;167(5):727–8.
Colao A, Petersenn S, et al. A 12-month phase 3 study of pasireotide in Cushing’s disease. N Engl J Med. 2012;366:914–24.
Nieman LK. Update in the medical therapy of Cushing’s disease. Curr Opin Endocrinol Diabetes Obes. 2013;20:330–4.
Pasini B, Stratakis CA. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma–paraganglioma syndromes. J Intern Med. 2009;266:19–42.
Manger W, Gifford RJ. Pheochromocytoma: a clinical review. In: Laragh J, Brenner B, editors. Hypertension: pathophysiology, diagnosis, and management, vol. 2. 2nd ed. New York: Raven Press; 1995. p. 2225–44.
Mazzaglia PJ. Hereditary pheochromocytoma and paraganglioma. J Surg Oncol. 2012;106:580–5.
Canu L, Rapizzi E, Zampetti B, et al. Pitfalls in genetic analysis of pheochromocytomas/paragangliomas – case report. J Clin Endocrinol Metab. 2014;99:2321–6.
Mariucci VL, Pacak K. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Curr Probl Cancer. 2014;38:7–41.
Barontini M, Levin G, Sanso G. Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci. 2006;1073:30–7.
Sloand EM, Thompson BT. Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma. Arch Intern Med. 1984;144:173–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer India
About this chapter
Cite this chapter
Subrahmanyam, P.E.R. (2016). Acute Thyroid and Adrenal Disorders. In: David, S. (eds) Clinical Pathways in Emergency Medicine. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2710-6_31
Download citation
DOI: https://doi.org/10.1007/978-81-322-2710-6_31
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2708-3
Online ISBN: 978-81-322-2710-6
eBook Packages: MedicineMedicine (R0)